Drug application
ORTHO TRI-CYCLEN 21 (ETHINYL ESTRADIOL, NORGESTIMATE)
Drugs@FDA NDA 021690 · ORTHO MCNEIL PHARM
Key facts
| Drug name | ORTHO TRI-CYCLEN 21 |
|---|---|
| Active ingredients | ETHINYL ESTRADIOL, NORGESTIMATE |
| Application type | NDA |
| Application number | 021690 |
| Company | ORTHO MCNEIL PHARM |
| Dosage forms | TABLET, ORAL-21 |
| Strength | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG |
| Marketing status | Prescription |
| Reference listed drug | No |
| Latest submission class | Type 6 - New Indication (no longer used) |
| Latest submission status date | May 13, 2005 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: